274 related articles for article (PubMed ID: 36522650)
1. Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data.
Kristófi R; Bodegard J; Ritsinger V; Thuresson M; Nathanson D; Nyström T; Norhammar A; Eriksson JW
Cardiovasc Diabetol; 2022 Dec; 21(1):282. PubMed ID: 36522650
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study.
Kristófi R; Bodegard J; Norhammar A; Thuresson M; Nathanson D; Nyström T; Birkeland KI; Eriksson JW
Diabetes Care; 2021 May; 44(5):1211-1218. PubMed ID: 33653822
[TBL] [Abstract][Full Text] [Related]
3. History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study.
Ritsinger V; Bodegård J; Kristofi R; Thuresson M; Nathanson D; Nyström T; Eriksson J; Norhammar A
BMJ Open; 2023 Apr; 13(4):e069037. PubMed ID: 37117003
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients.
Ducluzeau PH; Fauchier G; Herbert J; Semaan C; Halimi JM; Angoulvant D; Fauchier L
Diabetes Metab; 2023 May; 49(3):101429. PubMed ID: 36736892
[TBL] [Abstract][Full Text] [Related]
5. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.
Birkeland KI; Bodegard J; Eriksson JW; Norhammar A; Haller H; Linssen GCM; Banerjee A; Thuresson M; Okami S; Garal-Pantaler E; Overbeek J; Mamza JB; Zhang R; Yajima T; Komuro I; Kadowaki T
Diabetes Obes Metab; 2020 Sep; 22(9):1607-1618. PubMed ID: 32363737
[TBL] [Abstract][Full Text] [Related]
6. Impact of diabetes on the risk of subsequent fractures in 92,600 patients with an incident hip fracture: A Danish nationwide cohort study 2004-2018.
Vinther D; Thomsen RW; Furnes O; Gjertsen JE; Pedersen AB
Bone; 2024 Jul; 184():117104. PubMed ID: 38636621
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.
Htoo PT; Tesfaye H; Schneeweiss S; Wexler DJ; Everett BM; Glynn RJ; Kim SC; Najafzadeh M; Koeneman L; Farsani SF; Déruaz-Luyet A; Paik JM; Patorno E
JAMA Netw Open; 2022 Oct; 5(10):e2237606. PubMed ID: 36264574
[TBL] [Abstract][Full Text] [Related]
8. Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: Comparison with influenza and pre-pandemic data.
Dell'Aquila K; Lee J; Wang SH; Alamuri TT; Jennings R; Tang H; Mahesh S; Leong TJ; Fleysher R; Henninger EM; Veeraraghavan S; Mirhaji P; Hou W; Herold KC; Duong TQ
Diabetes Obes Metab; 2023 Sep; 25(9):2482-2494. PubMed ID: 37254311
[TBL] [Abstract][Full Text] [Related]
9. Lower heart failure and chronic kidney disease risks associated with sodium-glucose cotransporter-2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.
Komuro I; Kadowaki T; Bodegård J; Thuresson M; Okami S; Yajima T
Diabetes Obes Metab; 2021 Apr; 23 Suppl 2():19-27. PubMed ID: 33835641
[TBL] [Abstract][Full Text] [Related]
10. Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study.
Zareini B; Blanche P; D'Souza M; Elmegaard Malik M; Nørgaard CH; Selmer C; Gislason G; Kristensen SL; Køber L; Torp-Pedersen C; Schou M; Lamberts M
Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006260. PubMed ID: 32571092
[TBL] [Abstract][Full Text] [Related]
11. Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
Sattar N; McMurray J; Borén J; Rawshani A; Omerovic E; Berg N; Halminen J; Skoglund K; Eliasson B; Gerstein HC; McGuire DK; Bhatt D; Rawshani A
Circulation; 2023 Jun; 147(25):1872-1886. PubMed ID: 37154040
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database.
Blin P; Joubert M; Jourdain P; Zaoui P; Guiard E; Sakr D; Dureau-Pournin C; Bernard MA; Lassalle R; Thomas-Delecourt F; Bineau S; Moore N; Droz-Perroteau C
Cardiovasc Diabetol; 2024 Jan; 23(1):22. PubMed ID: 38195491
[TBL] [Abstract][Full Text] [Related]
13. Obesity and Chronic Kidney Disease in US Adults With Type 1 and Type 2 Diabetes Mellitus.
Wallace AS; Chang AR; Shin JI; Reider J; Echouffo-Tcheugui JB; Grams ME; Selvin E
J Clin Endocrinol Metab; 2022 Apr; 107(5):1247-1256. PubMed ID: 35080610
[TBL] [Abstract][Full Text] [Related]
14. Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection.
Tallon EM; Ebekozien O; Sanchez J; Staggs VS; Ferro D; McDonough R; Demeterco-Berggren C; Polsky S; Gomez P; Patel N; Prahalad P; Odugbesan O; Mathias P; Lee JM; Smith C; Shyu CR; Clements MA
Diabetes Res Clin Pract; 2022 Dec; 194():110156. PubMed ID: 36400172
[TBL] [Abstract][Full Text] [Related]
15. Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome.
Lee YB; Han K; Kim B; Jun JE; Lee SE; Ahn J; Kim G; Jin SM; Kim JH
Diabetes Metab Res Rev; 2019 Nov; 35(8):e3197. PubMed ID: 31222888
[TBL] [Abstract][Full Text] [Related]
16. Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study.
Lee YB; Han K; Kim B; Lee SE; Jun JE; Ahn J; Kim G; Jin SM; Kim JH
Cardiovasc Diabetol; 2019 Nov; 18(1):157. PubMed ID: 31733656
[TBL] [Abstract][Full Text] [Related]
17. Associations of New-Onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes.
Geng T; Wang Y; Lu Q; Zhang YB; Chen JX; Zhou YF; Wan Z; Guo K; Yang K; Liu L; Liu G; Pan A
Diabetes Care; 2022 Oct; 45(10):2422-2429. PubMed ID: 35984477
[TBL] [Abstract][Full Text] [Related]
18. Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study.
Modin D; Claggett B; Køber L; Schou M; Jensen JUS; Solomon SD; Vardeny O; Knop FK; Nielsen SD; Fralick M; Torp-Pedersen C; Gislason G; Biering-Sørensen T
Diabetes Care; 2020 Sep; 43(9):2226-2233. PubMed ID: 32647052
[TBL] [Abstract][Full Text] [Related]
19. Impact of type 2 diabetes on life expectancy and role of kidney disease among inpatients with heart failure in Switzerland: an ambispective cohort study.
Salvador D; Bano A; Wehrli F; Gonzalez-Jaramillo V; Laimer M; Hunziker L; Muka T
Cardiovasc Diabetol; 2023 Jul; 22(1):174. PubMed ID: 37438747
[TBL] [Abstract][Full Text] [Related]
20. Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study.
Pasea L; Dashtban A; Mizani M; Bhuva A; Morris T; Mamza JB; Banerjee A
Open Heart; 2023 Sep; 10(2):. PubMed ID: 37758654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
